Genetics and coronary artery disease: Present and future

Hellenic Journal of Cardiology

Volumn 55, Issue 2, 2014, Pages 156-163

  Bampali, Konstantina ^a   Mouzarou, Angeliki ^b   Lamnisou, Kleoniki ^a   Babalis, Dimitrios ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b KAT HOSPITAL   (Greece)

Author keywords

Coronary disease; Genetic variable; Genetics; Genome; Polymorphism

Indexed keywords

BLOOD PRESSURE; CORONARY ARTERY DISEASE; DNA MICROARRAY; DNA POLYMORPHISM; FAMILIAL HYPERCHOLESTEROLEMIA; GENETIC ASSOCIATION; GENETIC ENGINEERING; GENETIC PREDISPOSITION; HUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTHERN BLOTTING; GENETICS; PEDIGREE; RISK ASSESSMENT;

CORONARY ARTERY DISEASE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PEDIGREE; RISK ASSESSMENT; RISK FACTORS;

EID: 84897433930     PISSN: 11099666     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Lopez A, Mathers C, Ezzati M, et al. Global Burden of Disease and Risk Factors. World Health Organisation, 2008
2. Go AS, Mozaffarian D, Roger VL, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2013 update; a report from the American Heart Association. Circulation 2013; 127: e6-e245.
3. Schildkraut JM, Myers RH, Cupples LA, Kiely DK, Kannel WB. Coronary risk associated with age and sex of parental heart disease in the Framingham Study. Am J Cardiol. 1989; 64: 555-559.
4. Hopkins PN, Williams RR, Kuida H, et al. Family history as an independent risk factor for incident coronary artery disease in a high-risk cohort in Utah. Am J Cardiol. 1988; 62: 703-707.
5. Colditz GA, Rimm EB, Giovannucci E, Stampfer MJ, Ros-ner B, Willett WC. A prospective study of parental history of myocardial infarction and coronary artery disease in men. Am J Cardiol. 1991; 67: 933-938.
6. Allen G, Harvald B, Shields J. Measures of twin concordance. Acta Genet Stat Med. 1967; 17: 475-481.
7. Marenberg M, Risch N, Berkman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary artery disease in a study of twins. N Engl J Med. 1994; 330: 1041-1046.
8. Zdravkovic S, Wienke A, Pedersen NL, Marenberg ME, Yashin AI, De Faire U. Heritability of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins. J Intern Med. 2002; 252: 247-254.
9. Yusuf S, Hawken S, Ounpuu S, et al. INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the IN-TERHEART Study): case-control study. Lancet. 2004; 364: 937-952.
10. Cooper JA, Miller GJ, Humphries SE. A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study. Atherosclerosis. 2005; 181: 93-100.
11. Dubé JB, Hegele RA. Genetics 100 for cardiologists: basics of genome-wide association studies. Can J Cardiol. 2013; 29: 10-17.
12. Botstein D, White RL, Skolnick M, Davis RW. Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am J Hum Genet. 1980; 32: 314-331.
13. Mullis KB, Faloona FA. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol. 1987; 155: 335-350.
14. The International HapMap Project. Nature. 2003; 426: 789-796.
15. Roberts R, Stewart AF, Wells GA, Williams KA, Kavaslar N, McPherson R. Identifying genes for coronary artery disease: An idea whose time has come. Can J Cardiol. 2007; 23 Suppl A: 7A-15A.
16. Damani SB, Topol EJ. Future use of genomics in coronary artery disease. J Am Coll Cardiol. 2007; 50: 1933-1940.
17. Pullinger CR, Hennessy LK, Chatterton JE, et al. Familial li-gand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity. J Clin Invest. 1995; 95: 1225-1234.
18. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992; 359: 641-644.
19. Iacoviello L, Di Castelnuovo A, De Knijff P, et al. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. N Engl J Med. 1998; 338: 79-85.
20. Swerdlow DI, Holmes MV, Harrison S, Humphries S. The genetics of coronary heart disease. Br Med Bull. 2012; 102: 59-77.
21. Mortality in treated heterozygous familial hypercholesterol-aemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group. Atherosclerosis. 1999; 142: 105-112.
22. Neil A, Cooper J, Betteridge J, et al. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Eur Heart J. 2008; 29: 2625-2633.
23. Hegele RA. SNP judgments and freedom of association. Ar-terioscler Thromb Vasc Biol. 2002; 22: 1058-1061.
24. Mayer B, Erdmann J, Schunkert H. Genetics and heritabil-ity of coronary artery disease and myocardial infarction. Clin Res Cardiol. 2007; 96: 1-7.
25. Schunkert H, Erdmann J, Samani NJ. Genetics of myocardial infarction: a progress report. Eur Heart J. 2010; 31: 918-925.
26. McPherson R, Pertsemlidis A, Kavaslar N, et al. A common allele on chromosome 9 associated with coronary heart disease. Science. 2007; 316: 1488-1491.
27. Helgadottir A, Thorleifsson G, Manolescu A, et al. A common variant on chromosome 9p21 affects the risk of myocar-dial infarction. Science. 2007; 316: 1491-1493.
28. Samani NJ, Erdmann J, Hall AS, et al. Genomewide association analysis of coronary artery disease. N Engl J Med. 2007; 357: 443-453.
29. Roberts R, Stewart AF. Genes and coronary artery disease: where are we? J Am Coll Cardiol. 2012; 60: 1715-1721.
30. Large-scale gene-centric analysis identifies novel variants for coronary artery disease. PLoS Genet. 2011; 7: e1002260.
31. Roberts R, Stewart AF. Genetics of coronary artery disease in the 21st century. Clin Cardiol. 2012; 35: 536-540.
32. Peden JF, Farrall M. Thirty-five common variants for coronary artery disease: the fruits of much collaborative labour. Hum Mol Genet. 2011; 20: R198-205.
33. Dandona S, Stewart AF, Chen L, et al. Gene dosage of the common variant 9p21 predicts severity of coronary artery disease. J Am Coll Cardiol. 2010; 56: 479-486.
34. Patel RS, Su S, Neeland IJ, et al. The chromosome 9p21 risk locus is associated with angiographic severity and progression of coronary artery disease. Eur Heart J. 2010; 31: 3017-3023.
35. Ardissino D, Berzuini C, Merlini PA, et al. Influence of 9p21.3 genetic variants on clinical and angiographic outcomes in early-onset myocardial infarction. J Am Coll Cardi-ol. 2011; 58: 426-434.
36. Reilly MP, Li M, He J, et al. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet. 2011; 377: 383-392.
37. Paynter NP, Chasman DI, Buring JE, Shiffman D, Cook NR, Ridker PM. Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3. Ann Intern Med. 2009; 150: 65-72.
38. Muehlschlegel JD, Liu KY, Perry TE, et al. Chromosome 9p21 variant predicts mortality after coronary artery bypass graft surgery. Circulation. 2010; 122: S60-65.
39. Paynter NP, Chasman DI, Paré G, et al. Association between a literature-based genetic risk score and cardiovascular events in women. JAMA. 2010; 303: 631-637.
40. Ripatti S, Tikkanen E, Orho-Melander M, et al. A multilo-cus genetic risk score for coronary heart disease: case-control and prospective cohort analyses. Lancet. 2010; 376: 1393-1400.
41. Thanassoulis G, Peloso GM, Pencina MJ, et al. A genetic risk score is associated with incident cardiovascular disease and coronary artery calcium: the Framingham Heart Study. Circ Cardiovasc Genet. 2012; 5: 113-121.
42. Brautbar A, Pompeii LA, Dehghan A, et al. A genetic risk score based on direct associations with coronary heart disease improves coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC), but not in the Rotterdam and Framingham Offspring, Studies. Atherosclerosis. 2012; 223: 421-426.
43. Lluis-Ganella C, Subirana I, Lucas G, et al. Assessment of the value of a genetic risk score in improving the estimation of coronary risk. Atherosclerosis. 2012; 222: 456-463.
44. Pell JP. Almanac 2012: cardiovascular risk scores. The National Society Journals present selected research that has driven recent advances in clinical cardiology. Heart. 2012; 98: 1272-1277.
45. Visel A, Zhu Y, May D, et al. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature. 2010; 464: 409-412.
46. Harismendy O, Notani D, Song X, et al. 9p21 DNA variants associated with coronary artery disease impair interferon- signalling response. Nature. 2011; 470: 264-268.
47. Maouche S, Schunkert H. Strategies beyond genome-wide association studies for atherosclerosis. Arterioscler Thromb Vasc Biol. 2012; 32: 170-181.
48. Faita F, Vecoli C, Foffa I, Andreassi MG. Next generation sequencing in cardiovascular diseases. World J Cardiol. 2012; 4: 288-295.